Showing 6401-6420 of 7110 for: Cochrane Systematic Reviews Back
- Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home
Cochrane Systematic Reviews, 13-May-2008
It is known that many patients encounter a variety of problems in the first weeks after they have been discharged from hospital to home. In recent years many projects have addressed discharge planning, with the aim of reducing problems after discharge. Te
- Telephone support for women during pregnancy and the first six weeks postpartum
Cochrane Systematic Reviews, 9-Jul-2013
Telephone communication is increasingly being accepted as a useful form of support within health care. There is some evidence that telephone support may be of benefit in specific areas of maternity care such as to support breastfeeding and for women at ri
- Telerehabilitation for people with low vision
Cochrane Systematic Reviews, 27-Aug-2015
Low vision affects over 300 million people worldwide and can compromise both activities of daily living and quality of life. Rehabilitative training and vision assistive equipment (VAE) may help, but some visually impaired people have limited resources to
- Telerehabilitation for persons with multiple sclerosis
Cochrane Systematic Reviews, 8-Apr-2015
Telerehabilitation, an emerging method, extends rehabilitative care beyond the hospital, and facilitates multifaceted, often psychotherapeutic approaches to modern management of patients using telecommunication technology at home or in the community. Alth
- Telerehabilitation services for stroke
Cochrane Systematic Reviews, 13-Nov-2013
Telerehabilitation is an alternative way of delivering rehabilitation services. Information and communication technologies are used to facilitate communication between the healthcare professional and the patient in a remote location. The use of telerehabi
- Temozolomide for high grade glioma
Cochrane Systematic Reviews, 11-Feb-2015
High grade glioma (HGG) is an aggressive form of brain cancer. Treatment of HGG usually entails biopsy, or resection if safe, followed by radiotherapy. Temozolomide is a novel oral chemotherapy drug that penetrates into the brain and purportedly has a low
- Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals
Cochrane Systematic Reviews, 18-Jan-2011
The introduction of highly active antiretroviral therapy (ART) as treatment for HIV infection has greatly improved mortality and morbidity for adults and children living with HIV around the world. Two of the most common medications given in first-line ART
- Terbutaline pump maintenance therapy after threatened preterm labor for preventing preterm birth
Cochrane Systematic Reviews, 25-Mar-2014
This review has been updated by a new team. The new review title is:Chawanpaiboon S, Laopaiboon M, Lumbiganon P, Sangkomkamhang US, Dowswell T. Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes. Co
- Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes
Cochrane Systematic Reviews, 21-Mar-2014
After successful inhibition of threatened preterm labour women are at high risk of recurrent preterm labour. Terbutaline pump maintenance therapy has been used to reduce adverse neonatal outcomes. This review replaces an earlier Cochrane review, published
- Teriflunomide for multiple sclerosis
Cochrane Systematic Reviews, 22-Mar-2016
This is an update of the Cochrane review "Teriflunomide for multiple sclerosis" (first published in The Cochrane Library 2012, Issue 12).
- Terlipressin for acute esophageal variceal hemorrhage
Cochrane Systematic Reviews, 26-Oct-2008
Terlipressin (triglycyl lysine vasopressin) is a synthetic analogue of vasopressin, which has been used in the treatment of acute variceal haemorrhage. In contrast to vasopressin, terlipressin can be administered as intermittent injections instead of cont
- Terlipressin for hepatorenal syndrome
Cochrane Systematic Reviews, 20-Aug-2012
Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concerning mortality is equivocal.
- Testosterone for peri and postmenopausal women
Cochrane Systematic Reviews, 3-May-2010
The question of whether adding testosterone therapy to conventional postmenopausal hormone therapy (HT) is effective or safe is unresolved. Therefore, we aimed to determine the efficacy and safety of testosterone therapy for postmenopausal women using HT.
- Testosterone for schizophrenia
Cochrane Systematic Reviews, 18-Jan-2012
Recently, sex hormones such as estrogens and testosterone or its derivatives have been the focus of interest for treatment of persistent symptoms associated with schizophrenia.
- Tests to detect and inform the diagnosis of root caries
Cochrane Systematic Reviews, 7-Dec-2020
Root caries is a well-recognised disease, with increasing prevalence as populations age and retain more of their natural teeth into later life. Like coronal caries, root caries can be associated with pain, discomfort, tooth loss, and contribute significan
- Thalidomide and thalidomide analogues for induction of remission in Crohn's disease
Cochrane Systematic Reviews, 19-Jul-2009
Crohn's disease is a chronic relapsing condition of the alimentary tract with a high morbidity secondary to bowel inflammation. High levels of tumour necrosis factor-alpha (TNF-a) have been associated with the development of intestinal inflammation in Cro
- Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease
Cochrane Systematic Reviews, 19-Jul-2009
Maintenance of remission is a major issue in the management of Crohn's disease. Thalidomide, a tumour necrosis factor-alpha (TNF-a) inhibitor and its analogue, lenalidomide, may have a role in the management of Crohn's disease, but it is not clear whether
- Thalidomide for managing cancer cachexia
Cochrane Systematic Reviews, 11-Feb-2015
Cancer cachexia is a multidimensional syndrome characterised by wasting, loss of weight, loss of appetite, metabolic alterations, fatigue and reduced performance status. A significant number of patients with advanced cancer develop cachexia before death.
- The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma
Cochrane Systematic Reviews, 4-Jan-2022
Hepatocellular carcinoma is the sixth most common cancer worldwide. Hepatic resection is regarded as the curative therapy for hepatocellular carcinoma. However, only about 20% of people with hepatocellular carcinoma are candidates for resection, which hig
- The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all‐cause mortality in patients who undergo noncardiac surgery
Cochrane Systematic Reviews, 21-Dec-2021
The Revised Cardiac Risk Index (RCRI) is a widely acknowledged prognostic model to estimate preoperatively the probability of developing in-hospital major adverse cardiac events (MACE) in patients undergoing noncardiac surgery. However, the RCRI does not
